T. Rowe Price Associates’s Transcat TRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$714K Buy
7,695
+1,018
+15% +$83.1K ﹤0.01% 2463
2026
Q1
$491K Buy
6,677
+1,412
+27% +$99.4K ﹤0.01% 2466
2025
Q4
$299K Buy
5,265
+432
+9% +$26.9K ﹤0.01% 2644
2025
Q3
$354K Buy
4,833
+336
+7% +$27.1K ﹤0.01% 2524
2025
Q2
$387K Buy
4,497
+418
+10% +$34.2K ﹤0.01% 2420
2025
Q1
$304K Buy
4,079
+512
+14% +$42.9K ﹤0.01% 2466
2024
Q4
$378K Buy
3,567
+559
+19% +$62K ﹤0.01% 2404
2024
Q3
$364K Buy
3,008
+261
+10% +$32.4K ﹤0.01% 2388
2024
Q2
$329K Buy
2,747
+400
+17% +$47.2K ﹤0.01% 2379
2024
Q1
$262K Buy
2,347
+284
+14% +$30.1K ﹤0.01% 2501
2023
Q4
$226K Buy
+2,063
New +$198K ﹤0.01% 2490

Other funds holding TRNS

T. Rowe Price Associates's TRNS Position: Q2 2026 in Review

T. Rowe Price Associates increased its Transcat (TRNS) stake by 15% in Q2 2026, buying an estimated $83.1K and bringing the position to 7,695 shares worth $714K. The position accounts for ﹤0.01% of the portfolio, ranked #2463.

T. Rowe Price Associates first reported a position in TRNS in Q4 2023 and has held it in 11 quarters since. 172 funds tracked by Wall St. Rank hold TRNS as of Q2 2026.

  • T. Rowe Price Associates held 7,695 shares of Transcat worth $714K as of Q2 2026.
  • T. Rowe Price Associates bought 1,018 Transcat shares in Q2 2026, an estimated $83.1K.
  • Transcat made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2463 holding.
  • T. Rowe Price Associates first reported a position in Transcat in Q4 2023 and has held it in 11 quarters since.
  • 172 funds tracked by Wall St. Rank held Transcat as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.